Summary
This European consensus statement, produced jointly by the European Renal Osteodystrophy initiative of the European Renal Association and the European Society for Paediatric Nephrology, synthesises evidence on nutritional vitamin D supplementation in CKD patients across all stages, including those on dialysis and following kidney transplantation. The expert panel addresses the clinical rationale for vitamin D screening and correction in the context of recent large-scale trials that questioned the benefit of supplementation in the general population. The resulting clinical practice points are intended to guide clinicians managing CKD-mineral and bone disorder in both children and adults.
UK applicability
The consensus statement is directly applicable to UK clinical practice, as UK nephrologists operate within European clinical frameworks and the guidance covers populations managed under NHS renal services; UK clinicians should consider these recommendations alongside NICE and KDIGO guidance on CKD-MBD management.
Key measures
Serum 25-hydroxyvitamin D concentrations; clinical practice recommendations; skeletal and non-skeletal outcomes; CKD-mineral and bone disorder (CKD-MBD) parameters
Outcomes reported
The consensus statement evaluates the evidence for screening and correcting vitamin D deficiency across CKD stages, dialysis, and post-transplantation, formulating clinical practice points for both paediatric and adult populations. It considers skeletal and non-skeletal outcomes in light of recent large-scale trial evidence.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.